-
Hot Alert: Roundy’s (NYSE:RNDY), JPMorgan Chase & Co. (NYSE:JPM), Harmony Gold Mining Co. (NYSE:HMY), Momo Inc. (NASDAQ:MOMO), Magellan Midstream Partners (NYSE:MMP)
On Monday shares of Roundy’s, Inc. (NYSE:RNDY) closed at $4.49. Company’s sales growth for last 5 years was 0.60% and EPS growth for next 5 years is recorded as 10.00%. On May 18, Roundy’s, Inc. (NYSE:RNDY) announced that it has filed a prospectus supplement to a registration statement filed on Form S-3 with the U.S.…
-
Hot Stock List: Harmony Gold Mining (NYSE:HMY), BIND Therapeutics (NASDAQ:BIND), Quantum Fuel Systems Technologies Worldwide (NASDAQ:QTWW), Brookfield Asset Management (NYSE:BAM), Pfizer (NYSE:PFE)
On Tuesday shares of Harmony Gold Mining Co. (ADR) (NYSE:HMY) closed at $2.07. Company’s sales growth for last 5 years was 3.50%. On 21 April, Harmony Gold Mining Co. (ADR) (NYSE:HMY) announced that it continues to restructure its operations for long term profitability. The restructuring at Kusasalethu was completed and the full cost saving will…
-
Top News: Gilead Sciences Inc. (NASDAQ:GILD), Express Scripts Holding Company (NASDAQ:ESRX), Canadian Solar Inc. (NASDAQ:CSIQ), Harmony Gold Mining (NYSE:HMY), EMC Corporation (NYSE:EMC)
On Monday shares of Gilead Sciences Inc. (NASDAQ:GILD) closed at $97.79. Company’s sales growth for last 5 years was 28.80% and EPS growth for next 5 years is recorded as 13.22%. Gilead Sciences, Inc. (NASDAQ:GILD) and Royalty Pharma Collection Trust filed suit against Actavis on April 1, 2015 in the U.S. District Court for the…
-
Watch 5 Stocks: Medgenics (NYSEMKT:MDGN), BELLEROPHON THERAPEUTICS (NASDAQ:BLPH), Siliconware Precision Industries (NASDAQ:SPIL), Harmony Gold Mining (NYSE:HMY), Oil States International Inc. (NYSE:OIS)
On 13 February, Medgenics Inc. (NYSEMKT:MDGN) reported a loss of $6.2 million in its fourth quarter. The Wayne, Pennsylvania-based company said it had a loss of 30 cents per share. For the year, the company reported that its loss widened to $18.4 million, or $1 per share. On Wednesday shares of Medgenics, Inc. (NYSEMKT:MDGN) closed…
-
Keep Eyes on: Synthetic Biologics Inc. (NYSEMKT:SYN), National Bank of Greece (NYSE:NBG), Pattern Energy. (NASDAQ:PEGI), Harmony Gold Mining (NYSE:HMY), Freeport-McMoRan (NYSE:FCX)
Synthetic Biologics, Inc. (NYSE: SYN) announced positive topline safety and tolerability results from a Phase 1b clinical trial of SYN-004, the Company’s investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy. On Tuesday shares…
-
Investors Should Watch: Genetic Technologies Limited (NASDAQ:GENE), American Airlines (NASDAQ:AAL), First South Bancorp (NASDAQ:FSBK), Harmony Gold Mining (NYSE:HMY), Antares Pharma (NASDAQ:ATRS)
On Jan 29, Genetic Technologies Limited (NASDAQ:GENE) report that up to 6 new breast diagnosis/treatment centres are expected to begin offering BREVAGenplus(R) to their at-risk patients in a systematic broad fashion in the January to March timeframe, with a growing number of additional new breast and imaging centre customers expected to follow later in calendar…
-
Investors Are Gambling: Harmony Gold Mining (NYSE:HMY), American Airlines (NASDAQ:AAL), Cvent (NYSE:CVT), Northern Oil and Gas (NYSEMKT:NOG), Harley-Davidson (NYSE:HOG)
DragonWave Inc. (NASDAQ:DRWI) announced financial results for the third quarter of fiscal year 2015, ended November 30, 2014. Revenue for the third quarter of fiscal year 2015 was $47.3 million, compared with $37.9 million in the second quarter of fiscal year 2015 and $22.2 million in the third quarter of fiscal year 2014. DragonWave had…
-
Notable Stocks in Focus: Bristol-Myers Squibb (NYSE:BMY), Wolverine World Wide (NYSE:WWW), Health Care (NYSE:HCN), Fortress Investment (NYSE:FIG), Harmony Gold Mining (NYSE:HMY)
On 11 January Bristol-Myers Squibb Company (NYSE:BMY) announced that the Phase-III trial of its experimental lung-cancer treatment Opdivo has been terminated earlier-than-anticipated. The termination came after an independent monitoring committee concluded that the said drug had superior efficacy results, as compared to docetaxel, a chemotherapy drug used for treating lung cancer patients. On Tuesday shares…